About SOFIE
SOFIE is a company based in Culver City (United States) founded in 2008.. SOFIE has raised $43.1 million across 13 funding rounds from investors including DOE, National Cancer Institute and Jubilant Pharma. The company has 546 employees as of December 31, 2023. SOFIE has completed 1 acquisition, including Zevacor. SOFIE offers products and services including Tracers, Contract Manufacturing, and Education Programs. SOFIE operates in a competitive market with competitors including Advanced Accelerator Applications, AdvanCell, Ariceum Therapeutics, Mariana Oncology and ARTBIO, among others.
- Headquarter Culver City, United States
- Employees 546 as on 31 Dec, 2023
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sofie Biosciences
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SOFIE
SOFIE offers a comprehensive portfolio of products and services, including Tracers, Contract Manufacturing, and Education Programs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Products for molecular imaging and diagnostics in patients.
Manufacturing services for clinical radiopharmaceutical needs.
Programs to enhance PET technology and patient care.
Unlock access to complete
Unlock access to complete
Funding Insights of SOFIE
SOFIE has successfully raised a total of $43.1M across 13 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 13
- Last Round Last Round
-
First Round
First Round
(23 Nov 2010)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2024 | Amount | Private Equity Round - SOFIE | Valuation | Trilantic Capital Partners North America |
|
| Nov, 2020 | Amount | Series C - SOFIE | Valuation | Jubilant Pharma |
|
| Sep, 2017 | Amount | Grant - SOFIE | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SOFIE
SOFIE has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include DOE, National Cancer Institute and Jubilant Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stage agnostic VC firm investing primarily in the US
|
Founded Year | Domain | Location | |
|
Private equity investments are targeted at North American companies.
|
Founded Year | Domain | Location | |
|
Scientific and technical information is managed and disseminated by OSTI.GOV.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SOFIE
SOFIE has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Zevacor. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Radiolabeling & radiopharmaceutical manufacturing services for nuclear medicine and molecular imaging
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - SOFIE
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sofie Comparisons
Competitors of SOFIE
SOFIE operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advanced Accelerator Applications, AdvanCell, Ariceum Therapeutics, Mariana Oncology and ARTBIO, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceutical company developing targeted alpha therapies for cancer treatment
|
|
| domain | founded_year | HQ Location |
Developer of drugs for systemic targeted radiation therapy to treat cancer
|
|
| domain | founded_year | HQ Location |
Targeted radiopharmaceuticals for solid tumors are developed and pioneered.
|
|
| domain | founded_year | HQ Location |
Alpha radioligand therapies for cancer are developed using lead-212.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sofie
Frequently Asked Questions about SOFIE
When was SOFIE founded?
SOFIE was founded in 2008 and raised its 1st funding round 2 years after it was founded.
Where is SOFIE located?
SOFIE is headquartered in Culver City, United States. It is registered at Culver City, California, United States.
Who is the current CEO of SOFIE?
Patrick Phelps is the current CEO of SOFIE.
Is SOFIE a funded company?
SOFIE is a funded company, having raised a total of $43.1M across 13 funding rounds to date. The company's 1st funding round was a Grant of $2M, raised on Nov 23, 2010.
How many employees does SOFIE have?
As of Dec 31, 2023, the latest employee count at SOFIE is 546.
What does SOFIE do?
Sofie Biosciences is developing molecular imaging systems and radio-pharmaceuticals. The companys molecular imaging device uses positron emission tomography (PET). Its other products include radiochemistry synthesizers, small animal PET imaging cameras, PET probes. The companys products are used for diagnosis, staging, and treatment evaluation in oncology, neurology, cardiology, and immunology.
Who are the top competitors of SOFIE?
SOFIE's top competitors include Advanced Accelerator Applications, AdvanCell and Mariana Oncology.
What products or services does SOFIE offer?
SOFIE offers Tracers, Contract Manufacturing, and Education Programs.
How many acquisitions has SOFIE made?
SOFIE has made 1 acquisition, including Zevacor.
Who are SOFIE's investors?
SOFIE has 7 investors. Key investors include DOE, National Cancer Institute, Jubilant Pharma, OSTI.GOV, and Cycad Group.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.